Effect of Lower Leg Heating and Transcutaneous Electrical Nerve Stimulation on Exercise Capacity in Patients With PAD

NCT ID: NCT03462472

Last Updated: 2018-03-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-11-15

Study Completion Date

2018-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Peripheral arterial disease (PAD) is characterized by poor circulation in the lower extremities that often provokes claudication (leg pain, numbness, and heaviness) with physical exertion. The aim of this research protocol is to determine the effect of two non-invasive treatment modalities on leg blood flow and exercise capacity in those with PAD. Specifically, we are measuring popliteal artery blood flow (Doppler ultrasound), toe oxygen saturation, ankle-brachial index (ABI), and 6-minute walking distance (6MWD) in men and women who have intermittent claudication (Fontaine Stage II; Rutherford Category 1-2) in response to 15 or 45 minutes of lower limb heating and transcutaneous electrical nerve stimulation (TENS).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peripheral Arterial Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

15 minute lower leg heating

Group Type EXPERIMENTAL

Lower leg heating

Intervention Type BEHAVIORAL

Immersion of lower legs in a circulating water bath at a temperature of 42 degrees Celsius

45 minute lower leg heating

Group Type EXPERIMENTAL

Lower leg heating

Intervention Type BEHAVIORAL

Immersion of lower legs in a circulating water bath at a temperature of 42 degrees Celsius

Control

Group Type NO_INTERVENTION

No interventions assigned to this group

15 minute lower leg TENS

Group Type EXPERIMENTAL

Lower leg transcutaneous electrical nerve stimulation (TENS)

Intervention Type BEHAVIORAL

Bilateral lower leg transcutaneous electrical nerve stimulation (TENS) using burst mode at a 3Hz burst rate, 100Hz frequency, and 250 µs pulse duration, sufficient to evoke skeletal muscle contraction

45 minute lower leg TENS

Group Type EXPERIMENTAL

Lower leg transcutaneous electrical nerve stimulation (TENS)

Intervention Type BEHAVIORAL

Bilateral lower leg transcutaneous electrical nerve stimulation (TENS) using burst mode at a 3Hz burst rate, 100Hz frequency, and 250 µs pulse duration, sufficient to evoke skeletal muscle contraction

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lower leg heating

Immersion of lower legs in a circulating water bath at a temperature of 42 degrees Celsius

Intervention Type BEHAVIORAL

Lower leg transcutaneous electrical nerve stimulation (TENS)

Bilateral lower leg transcutaneous electrical nerve stimulation (TENS) using burst mode at a 3Hz burst rate, 100Hz frequency, and 250 µs pulse duration, sufficient to evoke skeletal muscle contraction

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Intermittent claudication (Fontaine Stage II)
* Resting ankle-brachial index (ABI) \< 0.90
* Ability to walk \> 60 meters in six minutes

Exclusion Criteria

* Body mass index (BMI) \> 35 kg/m2
* Severe exercise limitations (more than PAD) due to co-morbidity
* Taking illegal/recreational drugs
* Uncontrolled hypertension (\>180/100 mmHg)
* Severe peripheral neuropathy
* Foot ulcers
* Gangrene
* Pregnant or breast feeding
Minimum Eligible Age

40 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Salisbury University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas K. Pellinger, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

Salisbury University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Salisbury University

Salisbury, Maryland, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tom Pellinger, Ph.D.

Role: CONTACT

410-677-0144

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Tom Pellinger, Ph.D.

Role: primary

410-677-0144

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

11112015-2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.